Thermo Fisher Scientific (TMO, Life Sciences Tools & Services) Stock Valuation & Fair Value Significantly overvalued
Thermo Fisher Scientific (TMO, Life Sciences Tools & Services) trades at a blended P/E of 25.8, about 28% above its historical normal valuation, with a forward growth estimate of 9.6% and a PEG of 2.68. Analysts' one-year estimates have been hit 82% of the time.
The Street vs SeerForecast
Wall Street's mean price target for TMO is $631.42 across 26 analysts, 0.3% above the current price. The average analyst rating is Buy. Our SeerForecast read of the same stock, formed without analyst targets: significantly overvalued. When the two disagree, start your digging there.
Valuation flags
- Overvalued by 28%
- Overbought (RSI 74)
Verdict history
tickerseer's rating moved from trading above fair value (2026-06-03) to significantly overvalued (2026-08-21).
Not every point was recorded live. Points marked recalculated apply today's valuation rules to the metrics tickerseer archived that week.
Frequently asked questions
Is Thermo Fisher Scientific stock overvalued?
At a blended P/E of 25.8 versus its historical normal P/E of 20.2, Thermo Fisher Scientific trades about 28% above its typical valuation, with a PEG of 2.68 on 9.6% forward growth. tickerseer currently rates it significantly overvalued.
What is Thermo Fisher Scientific's fair value and PEG?
Thermo Fisher Scientific trades at a blended P/E of 25.8 against a historical normal P/E of 20.2, a PEG of 2.68, and a forward growth estimate of 9.6%.
Has tickerseer's rating of Thermo Fisher Scientific changed?
tickerseer's rating moved from trading above fair value (2026-06-03) to significantly overvalued (2026-08-21).
What is the analyst price target for Thermo Fisher Scientific?
The mean Wall Street price target for Thermo Fisher Scientific is $631.42 across 26 analysts, 0.3% above the current price. tickerseer's SeerForecast verdict is formed independently of analyst targets.
Industry: Life Sciences Tools & Services. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.
Get the free weekly earnings preview
One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.
It's free, and you can unsubscribe any time. Educational content, not investment advice.